• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自主神经失衡增加非酒精性脂肪性肝病的风险。

Autonomic Imbalance Increases the Risk for Non-alcoholic Fatty Liver Disease.

机构信息

Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.

出版信息

Front Endocrinol (Lausanne). 2021 Nov 8;12:752944. doi: 10.3389/fendo.2021.752944. eCollection 2021.

DOI:10.3389/fendo.2021.752944
PMID:34819920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8606663/
Abstract

BACKGROUND

Although autonomic imbalance is associated with an increased risk for metabolic disease, its effects on nonalcoholic fatty liver disease (NAFLD) remains unclear. We aimed to evaluate whether autonomic dysfunction predicts the risk for nonalcoholic fatty liver disease (NAFLD).

METHODS

A total of 33,899 participants without NAFLD who underwent health screening programs between 2011 and 2018 were enrolled. NAFLD was identified by ultrasonography. Autonomic activity was estimated using heart rate variability (HRV). Time domain [standard deviation of the normal-to-normal interval (SDNN) and root mean square difference (RMSSD)]; frequency domain [total power (TP), low frequency (LF), and high frequency (HF), and LF/HF ratio were analyzed.

FINDINGS

A total 6,466 participants developed NAFLD within a median of 5.7 years. Subjects with incident NAFLD showed decreased overall autonomic modulation and vagal activity with lowered SDNN, RMSSD, HF, normalized HF, compared to those without NAFLD. As the SDNN, RMSSD, TP, LF, and HF tertiles increased, the risk of NAFLD decreased with tertile 1 being the reference group [the hazard ratios (95% confidence intervals) of tertile 3 were 0.90 (0.85-0.96), 0.83 (0.78-0.88), 0.91 (0.86-0.97), 0.93 (0.87-0.99) and 0.89 (0.83-0.94), respectively] after adjusting for potential confounders. The risk for NAFLD was significantly higher in subjects in whom sustained elevated heart rate, normalized LF, and LF/HF ratio values than in those with sustained decrease in these parameters during follow-up.

CONCLUSIONS

Overall autonomic imbalance, decreased parasympathetic activity, and recently increased sympathetic activity might increase the risk of NAFLD.

摘要

背景

尽管自主神经失衡与代谢性疾病风险增加有关,但它对非酒精性脂肪性肝病(NAFLD)的影响尚不清楚。我们旨在评估自主神经功能障碍是否可预测非酒精性脂肪性肝病(NAFLD)的风险。

方法

共纳入 2011 年至 2018 年间接受健康筛查计划且无 NAFLD 的 33899 名参与者。通过超声检查来确定 NAFLD。使用心率变异性(HRV)来评估自主活动。时域[正常-正常间期标准差(SDNN)和均方根差(RMSSD)];频域[总功率(TP)、低频(LF)和高频(HF),以及 LF/HF 比值]进行分析。

结果

在中位随访 5.7 年内,共有 6466 名参与者发生了 NAFLD。与无 NAFLD 者相比,发生 NAFLD 的患者整体自主调节和迷走神经活动下降,SDNN、RMSSD、HF、归一化 HF 降低。与参考组(第 1 三分位数)相比,随着 SDNN、RMSSD、TP、LF 和 HF 三分位数的增加,NAFLD 的风险降低(第 3 三分位数的危险比(95%置信区间)分别为 0.90(0.85-0.96)、0.83(0.78-0.88)、0.91(0.86-0.97)、0.93(0.87-0.99)和 0.89(0.83-0.94)),在调整了潜在混杂因素后。与这些参数持续下降的患者相比,持续升高的心率、归一化 LF 和 LF/HF 比值的患者发生 NAFLD 的风险显著更高。

结论

整体自主神经失衡、副交感神经活性降低和近期交感神经活性增加可能会增加 NAFLD 的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9118/8606663/7f3c899c8248/fendo-12-752944-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9118/8606663/d5c397b1921f/fendo-12-752944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9118/8606663/7b8d26d32f2c/fendo-12-752944-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9118/8606663/7f3c899c8248/fendo-12-752944-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9118/8606663/d5c397b1921f/fendo-12-752944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9118/8606663/7b8d26d32f2c/fendo-12-752944-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9118/8606663/7f3c899c8248/fendo-12-752944-g003.jpg

相似文献

1
Autonomic Imbalance Increases the Risk for Non-alcoholic Fatty Liver Disease.自主神经失衡增加非酒精性脂肪性肝病的风险。
Front Endocrinol (Lausanne). 2021 Nov 8;12:752944. doi: 10.3389/fendo.2021.752944. eCollection 2021.
2
Influence of non-alcoholic fatty liver disease on autonomic changes evaluated by the time domain, frequency domain, and symbolic dynamics of heart rate variability.非酒精性脂肪性肝病对心率变异性时域、频域和符号动力学指标评估的自主神经变化的影响。
PLoS One. 2013 Apr 23;8(4):e61803. doi: 10.1371/journal.pone.0061803. Print 2013.
3
Assessment of sympathovagal balance by HRV analysis in alcoholic and nonalcoholic fatty liver disease patients.通过心率变异性分析评估酒精性和非酒精性脂肪性肝病患者的交感迷走神经平衡。
J Educ Health Promot. 2023 Nov 27;12:400. doi: 10.4103/jehp.jehp_449_23. eCollection 2023.
4
Body mass index contributes to sympathovagal imbalance in prehypertensives.体质指数与高血压前期患者的交感迷走神经失衡有关。
BMC Cardiovasc Disord. 2012 Jul 19;12:54. doi: 10.1186/1471-2261-12-54.
5
Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study.非酒精性脂肪性肝病与 2 型糖尿病患者和非糖尿病患者心脏自主神经平衡受损的关系——南蒂罗尔合作健康研究(CHRIS)-非酒精性脂肪性肝病亚研究。
Nutr Metab Cardiovasc Dis. 2021 Nov 29;31(12):3464-3473. doi: 10.1016/j.numecd.2021.08.037. Epub 2021 Aug 24.
6
Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease.10 秒心电图的低心率变异性与非酒精性脂肪性肝病的发展有关。
Sci Rep. 2022 Jan 20;12(1):1062. doi: 10.1038/s41598-022-05037-w.
7
Decreased Vagal Activity and Deviation in Sympathetic Activity Precedes Development of Diabetes.迷走神经活动减少和交感神经活动偏差先于糖尿病的发展。
Diabetes Care. 2020 Jun;43(6):1336-1343. doi: 10.2337/dc19-1384. Epub 2020 Apr 16.
8
Effect of Guizhi Decoction ([symbols; see text]) on heart rate variability and regulation of cardiac autonomic nervous imbalance in diabetes mellitus rats.桂枝汤对糖尿病大鼠心率变异性及心脏自主神经失衡调节的影响。
Chin J Integr Med. 2014 Jul;20(7):524-33. doi: 10.1007/s11655-014-1861-z. Epub 2014 Jun 28.
9
Standardized tests of heart rate variability for autonomic function tests in healthy Koreans.韩国健康人群自主神经功能测试中心率变异性的标准化测试
Int J Neurosci. 2007 Dec;117(12):1707-17. doi: 10.1080/00207450601050097.
10
A systematic review and meta-analysis of heart rate variability in epilepsy and antiepileptic drugs.癫痫与抗癫痫药物治疗中心率变异性的系统评价和荟萃分析。
Epilepsia. 2012 Feb;53(2):272-82. doi: 10.1111/j.1528-1167.2011.03361.x. Epub 2012 Jan 5.

引用本文的文献

1
Effects of sleep deprivation on heart rate variability: a systematic review and meta-analysis.睡眠剥夺对心率变异性的影响:一项系统评价与荟萃分析。
Front Neurol. 2025 Aug 14;16:1556784. doi: 10.3389/fneur.2025.1556784. eCollection 2025.
2
The association between inflammatory, metabolic, and hepatic fibrosis-related biomarkers and atrial fibrillation in older patients with metabolic dysfunction-associated steatotic liver disease.炎症、代谢及肝纤维化相关生物标志物与老年代谢功能障碍相关脂肪性肝病患者心房颤动之间的关联。
BMC Geriatr. 2025 Jul 2;25(1):459. doi: 10.1186/s12877-025-06120-3.
3
PI3K/AKT signaling pathway plays an important role in the pathogenesis of metabolic dysfunction-associated steatotic liver disease.

本文引用的文献

1
Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study.非酒精性脂肪性肝病与 2 型糖尿病患者和非糖尿病患者心脏自主神经平衡受损的关系——南蒂罗尔合作健康研究(CHRIS)-非酒精性脂肪性肝病亚研究。
Nutr Metab Cardiovasc Dis. 2021 Nov 29;31(12):3464-3473. doi: 10.1016/j.numecd.2021.08.037. Epub 2021 Aug 24.
2
Increased Risk of Nonalcoholic Fatty Liver Disease in Individuals with High Weight Variability.体重波动大的个体患非酒精性脂肪性肝病的风险增加。
Endocrinol Metab (Seoul). 2021 Aug;36(4):845-854. doi: 10.3803/EnM.2021.1098. Epub 2021 Aug 27.
3
PI3K/AKT信号通路在代谢功能障碍相关脂肪性肝病的发病机制中起重要作用。
Sci Rep. 2025 Jul 1;15(1):20593. doi: 10.1038/s41598-025-07612-3.
4
Beta-cell, but not autonomic nervous system, function is related to MAFLD in early stages of glucose intolerance.在葡萄糖不耐受早期,β细胞功能而非自主神经系统功能与MAFLD相关。
BMJ Open Diabetes Res Care. 2024 Dec 20;12(6):e004542. doi: 10.1136/bmjdrc-2024-004542.
5
Interaction between the systemic immune-inflammation index and trouble sleeping in nonalcoholic fatty liver disease: a cross-sectional study of the NHANES 2005-2018 data.非酒精性脂肪性肝病患者的全身免疫炎症指数与睡眠障碍的关系:NHANES 2005-2018 数据的横断面研究。
J Health Popul Nutr. 2024 Oct 30;43(1):175. doi: 10.1186/s41043-024-00670-9.
6
The Neuroimmune Axis and Its Therapeutic Potential for Primary Liver Cancer.神经免疫轴及其在原发性肝癌治疗中的潜在作用。
Int J Mol Sci. 2024 Jun 5;25(11):6237. doi: 10.3390/ijms25116237.
7
Associations of ALT/AST, a marker of hepatosteatosis, with pulse rate in young women and with blood pressure in middle-aged women independently of abdominal fat accumulation and insulin resistance.肝脂肪变性标志物谷丙转氨酶/谷草转氨酶(ALT/AST)与年轻女性的脉搏率以及中年女性的血压之间的关联独立于腹部脂肪堆积和胰岛素抵抗。
Diabetol Int. 2024 Jan 24;15(2):270-277. doi: 10.1007/s13340-023-00689-z. eCollection 2024 Apr.
8
Assessment of sympathovagal balance by HRV analysis in alcoholic and nonalcoholic fatty liver disease patients.通过心率变异性分析评估酒精性和非酒精性脂肪性肝病患者的交感迷走神经平衡。
J Educ Health Promot. 2023 Nov 27;12:400. doi: 10.4103/jehp.jehp_449_23. eCollection 2023.
9
Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective.胰岛素抵抗、非酒精性脂肪性肝病和 2 型糖尿病:临床与实验视角。
Diabetes Metab J. 2024 May;48(3):327-339. doi: 10.4093/dmj.2023.0350. Epub 2024 Feb 2.
10
Multi-Organ Increase in Norepinephrine Levels after Central Leptin Administration and Diet-Induced Obesity.中枢给予瘦素和饮食诱导肥胖后多器官去甲肾上腺素水平增加。
Int J Mol Sci. 2023 Nov 29;24(23):16909. doi: 10.3390/ijms242316909.
Autonomic Nervous System in Obesity and Insulin-Resistance-The Complex Interplay between Leptin and Central Nervous System.
肥胖与胰岛素抵抗中的自主神经系统——瘦素与中枢神经系统之间的复杂相互作用。
Int J Mol Sci. 2021 May 14;22(10):5187. doi: 10.3390/ijms22105187.
4
Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally.非酒精性脂肪性肝病的多样性:全球不同种族非酒精性脂肪性肝病表现的综述
J Clin Transl Hepatol. 2021 Feb 28;9(1):71-80. doi: 10.14218/JCTH.2020.00082. Epub 2020 Dec 14.
5
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment.非酒精性脂肪性肝病,以及心血管和心脏疾病:影响风险、预测和治疗的因素。
Diabetes Metab. 2021 Mar;47(2):101215. doi: 10.1016/j.diabet.2020.101215. Epub 2020 Dec 6.
6
Severity of Nonalcoholic Fatty Liver Disease and Risk of Future Ischemic Stroke Events.非酒精性脂肪性肝病严重程度与未来缺血性卒事件风险的关系。
Stroke. 2021 Jan;52(1):103-110. doi: 10.1161/STROKEAHA.120.030433. Epub 2020 Dec 4.
7
Prevalence of Fatty Liver Disease and Fibrosis Detected by Transient Elastography in Adults in the United States, 2017-2018.2017-2018 年美国成年人通过瞬时弹性成像技术检测到的脂肪肝疾病和纤维化的流行率。
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1499-1501.e2. doi: 10.1016/j.cgh.2020.08.017. Epub 2020 Aug 12.
8
Decreased Vagal Activity and Deviation in Sympathetic Activity Precedes Development of Diabetes.迷走神经活动减少和交感神经活动偏差先于糖尿病的发展。
Diabetes Care. 2020 Jun;43(6):1336-1343. doi: 10.2337/dc19-1384. Epub 2020 Apr 16.
9
Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study.英国年轻人脂肪性肝病和肝纤维化的流行情况:一项基于人群的研究。
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):295-305. doi: 10.1016/S2468-1253(19)30419-4. Epub 2020 Jan 15.
10
Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management.非酒精性脂肪性肝病:流行病学、风险因素、诊断和治疗的综述。
Intern Med J. 2020 Sep;50(9):1038-1047. doi: 10.1111/imj.14709.